BMGL 6-K SEC Filing Analysis

Latest settled — T+20d

BMGL ▲ +13.27% at T+20d

NEUTRAL call ✓ call won +13.27% · α vs SPY +0.68% · entry $0.5500 → $0.6230

Next anchor: T+60d in 15d

Last close $0.5950 (close Jun 8) · +8.18% from $0.5500 entry

Entry anchored
Mar 27, 03:58 PM ET
via Databento tick

T+1d

+7.27%

call +7.27% · α +4.38%

$0.5900

settled 2mo ago

T+5d

+8.18%

call +8.18% · α +3.88%

$0.5950

settled 2mo ago

T+20d

+13.27%

call +13.27% · α +0.68%

$0.6230

settled 6w ago

T+60d

—

call — · α —

—

in 15d

Price Chart

Loading chart...

Executive Summary

Basel Medical Group Ltd appointed Mr. Tan Boon Chye (Darren), its Chief Commercial Officer, to the board of directors, replacing Ms. Jianing Lu who resigned from the board. Ms. Lu remains as CFO, indicating continuity in financial leadership. This is a routine board reshuffle with no immediate financial implications.

Actionable Insight

Monitor for any subsequent commentary on strategic direction or governance changes, but this filing alone does not suggest material operational or financial shifts. The retention of Ms. Lu as CFO reduces execution risk.

Key Facts

Mr. Tan Boon Chye (Darren), Chief Commercial Officer, appointed to the board of directors
Ms. Jianing Lu resigned from the board but continues as Chief Financial Officer
Board change effective as of March 30, 2026
No financial terms or strategic shifts disclosed in the filing

Financial Impact

No direct financial impact disclosed

none

Risk Factors

Potential governance concerns if board stability becomes an ongoing issue
Limited immediate risk given CFO continuity

Market Snapshot

Exchange

Nasdaq

Sector

Services-Offices & Clinics of Doctors of Medicine

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
6-K Filing (Primary)	0001493152-26-013458
Document: 0001493152-26-013458-index-headers.html	0001493152-26-013458
Document: 0001493152-26-013458-index.html	0001493152-26-013458
Document: 0001493152-26-013458.txt	0001493152-26-013458

3 reports for BMGL

T+1T+5T+20T+60

Filters

Reports for BMGL — sortable, filterable
	Type				Now
Jun 5, 2026 4d ago	6-K NEUTRAL ★ 3/10	$0.3735 awaiting T+20	awaiting T+20	—	$0.5950 (+59.30%)
Mar 30, 2026 10w ago	6-K NEUTRAL ★ 3/10	$0.5500 $0.6230	▲ +13.27%	▲ +0.68%	$0.5950 (+8.18%)
Mar 24, 2026 11w ago	Press Release NEUTRAL ★ 3/10	$0.6400 $0.6200	▼ −3.13%	▼ −12.03%	$0.5950 (−7.03%)

US Market Status

Market Closed — Opens in 7h 19m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access